Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
26.8
EUR
-1.43%
Market Cap:
€1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
Page Industries Ltd
BSE:532827
|
IN |
|
P
|
Pico Far East Holdings Ltd
F:PJFB
|
HK |
|
Mahasagar Travels Ltd
BSE:526795
|
IN |
|
Pexip Holding ASA
F:4W9
|
NO |
|
P
|
Prime Drink Group Corp
CNSX:PRME
|
CA |
|
M
|
Mirai Semiconductors Co Ltd
KOSDAQ:254490
|
KR |
|
H
|
Hiremii Ltd
ASX:HMI
|
AU |
|
Triple Flag Precious Metals Corp
NYSE:TFPM
|
CA |
|
Equillium Inc
NASDAQ:EQ
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Celldex Therapeutics Inc (TCE2) under the Base Case is hidden
EUR.
Compared with the current market price of 26.8 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TCE2 Multiples-Based Value
LOCKED